For the Inventor, By the Inventor

Enter assignee name

Montreal, Canada

Universitéde Montreal

Calculating rank

USPTO Granted Patents = 189

% Expired Patents = 21.7

CIPO Patents = 27

EPO Patents = 58

Forward Citations = 2,170

Loading Chart...

Loading Chart...

410 inventors (with patents filed for the assignee):

Nathalie Ravet (19 out of 27 patents)

Michel Armand (16 out of 72 patents)

Christophe Michot (15 out of 58 patents)

4. Michel Gauthier (11 out of 81 patents)

5. Jocelyn Faubert (11 out of 18 patents)

6. Guy Sauvageau (10 out of 12 patents)

7. Jean-François Magnan (9 out of 33 patents)

8. Christer Sinderby (9 out of 31 patents)

9. Edward H Ruediger (8 out of 52 patents)

10. Michel Bouvier (8 out of 13 patents)

11. Martin Simoneau (8 out of 13 patents)

12. Simon Besner (8 out of 15 patents)

13. Jacques Banville (8 out of 27 patents)

14. Shoshana L Posy (7 out of 34 patents)

15. Eldon Scott Priestley (7 out of 24 patents)

Core Competencies:

Cyclic Peptides

Biosensors

Hematopoietic Stem Cells

Pharmaceutical Composition

Platelet Aggregation Inhibitors

Progressive Lens Systems

Optical Systems

Immunization Vectors

Mitochondrial Activity Inhibitors

Polymorphic Screening

G-Protein Activation

189 patents: Sort by Forward Citations

1. 12721812 - Method for stimulating T cell response against lymphoblastic leukemia with leukemia tumor specific antigens (2026-09-01),

2. 12692289 - TUMOR-SPECIFIC PEPTIDE ANTIGENS FOR OVARIAN CANCER AND USES THEREOF (2026-07-28),

3. 12670439 - Generating locally invariant explanations for machine learning (2026-06-30),

4. 12616760 - Synthetic cyclic peptide mimetics (2026-05-05),

5. 12561548 - System simulating a decisional process in a mammal brain about motions of a visually observed body (2026-02-24),

6. 12534827 - Methods for polymorphic screening (2026-01-27),

7. 12479842 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease (2025-11-25),

8. 12386199 - Method for determining a progressive lens and associated system (2025-08-12),

9. 12360400 - Method for determining a progressive lens and associated system (2025-07-15),

10. 12286559 - Method for plasma deposition of anti-fog coatings (2025-04-29),

11. 12286426 - Heterocyclic mitochondrial activity inhibitors and uses thereof (2025-04-29),

12. 12139488 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease (2024-11-12),

13. 12092903 - Method for adapting ophthalmic equipment according to a wearers visual exploration strategy (2024-09-17),

14. 12084452 - Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation (2024-09-10),

15. 12060353 - Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease (2024-08-13),

Company Overview

Université de Montréal is a leading research institution located in Montreal, Canada, specializing in biomedical innovations. The university is at the forefront of developing advanced technologies in areas such as cyclic peptides, biosensors, and hematopoietic stem cells. Its research extends to pharmaceutical compositions and platelet aggregation inhibitors, contributing significantly to medical science. Additionally, the institution explores optical systems and immunization vectors, fostering innovation in healthcare and enhancing therapeutic strategies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

189 Patents

#5 in Montreal

#59 in Canada

#4,457 in the World

Montreal, Canada

Universitéde Montreal

Forward Citations = 2,170

410 inventors:

Nathalie Ravet (19 out of 27 patents)

Michel Armand (16 out of 72 patents)

Christophe Michot (15 out of 58 patents)

4. Michel Gauthier (11 out of 81 patents)

5. Jocelyn Faubert (11 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Universitéde Montreal. Retrieved from https://idiyas.com/company/universitede-montreal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…